Thompson, Alexander J.
4 papers on CoChatORCID 0000-0001-9882-0071
Most cited papers
- Verified
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 545
- Verified
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
Fellay, J., Thompson, A. J., Ge, D., Gumbs, C. E., Urban, T. J., Shianna, K. V., Little, L. D., Qiu, P., Bertelsen, A. H., Watson, M., et al. (2010) · Nature
Hepatitis C virus researchPharmacogenetics and Drug Metabolism
Cited by 441
- Verified
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial
Basnayake, C., Kamm, M. A., Stanley, A., Wilson-O'Brien, A., Burrell, K., Lees-Trinca, I., Khera, A., Kantidakis, J., Wong, O., Fox, K., et al. (2020) · The Lancet Gastroenterology & Hepatology
Gastrointestinal motility and disordersPsychosomatic Disorders and Their Treatments
Cited by 128
- Verified
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial
Mayo, M. J., Wigg, A. J., Leggett, B. A., Arnold, H., Thompson, A. J., Weltman, M., Carey, E. J., Muir, A. J., Ling, L., Rossi, S. J., et al. (2018) · Hepatology Communications
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 125
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free